Literature DB >> 21232526

MicroRNAs and their target gene networks in renal cell carcinoma.

Martina Redova1, Marek Svoboda, Ondrej Slaby.   

Abstract

MicroRNAs (miRNAs) are non-protein-coding short single stranded RNAs in the size range 19-25 nucleotides that are associated with gene regulation at the transcriptional and translational level. Recent studies have proved that miRNAs play important roles in a large number of biological processes, including cellular differentiation, proliferation, apoptosis, etc. Changes in their expression were found in a variety of human cancers, including renal cell carcinoma pathogenesis. Specific miRNA alterations were associated with key pathogenetic mechanisms of renal cell carcinoma like hypoxia or epithelial-mesenchymal transition. In this review, we summarize the current knowledge of miRNA functions in renal cell carcinoma with an emphasis on miRNAs potential to serve as a powerful biomarker of disease and a novel therapeutic target in oncology.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232526     DOI: 10.1016/j.bbrc.2011.01.019

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.

Authors:  Kejia Wang; Qing Liang; Li Wei; Wei Zhang; Ping Zhu
Journal:  Tumour Biol       Date:  2015-10-16

2.  mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in mice.

Authors:  Brandi N Snyder-Talkington; Chunlin Dong; Linda M Sargent; Dale W Porter; Lauren M Staska; Ann F Hubbs; Rebecca Raese; Walter McKinney; Bean T Chen; Lori Battelli; David T Lowry; Steven H Reynolds; Vincent Castranova; Yong Qian; Nancy L Guo
Journal:  J Appl Toxicol       Date:  2015-04-29       Impact factor: 3.446

3.  TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93.

Authors:  J Shi; Y Zhuang; X K Liu; Y X Zhang; Y Zhang
Journal:  Clin Transl Oncol       Date:  2014-09-03       Impact factor: 3.405

4.  Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses.

Authors:  Heba W Z Khella; Nicole M A White; Hala Faragalla; Manal Gabril; Mina Boazak; David Dorian; Bishoy Khalil; Hany Antonios; Tian Tian Bao; Maria D Pasic; R John Honey; Robert Stewart; Kenneth T Pace; Georg A Bjarnason; Michael A S Jewett; George M Yousef
Journal:  Tumour Biol       Date:  2011-11-16

5.  Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer.

Authors:  Renata Hezova; Alena Kovarikova; Julie Bienertova-Vasku; Milana Sachlova; Martina Redova; Anna Vasku; Marek Svoboda; Lenka Radova; Igor Kiss; Rostislav Vyzula; Ondrej Slaby
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

6.  MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma.

Authors:  Yongqing Gao; Hongmei Zhao; Ying Lu; Haiyi Li; Gaobo Yan
Journal:  Tumour Biol       Date:  2014-08-06

7.  MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Authors:  Martina Redova; Alexandr Poprach; Andrej Besse; Robert Iliev; Jana Nekvindova; Radek Lakomy; Lenka Radova; Marek Svoboda; Jan Dolezel; Rostislav Vyzula; Ondrej Slaby
Journal:  Tumour Biol       Date:  2012-11-13

Review 8.  Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved.

Authors:  Karthigayan Shanmugasundaram; Karen Block
Journal:  Antioxid Redox Signal       Date:  2016-07-27       Impact factor: 8.401

Review 9.  Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer.

Authors:  Jieting Zhang; Yan Wang; Xiaohua Jiang; Hsiao Chang Chan
Journal:  Cell Mol Life Sci       Date:  2018-02-06       Impact factor: 9.261

Review 10.  Novel classes of non-coding RNAs and cancer.

Authors:  Jiri Sana; Petra Faltejskova; Marek Svoboda; Ondrej Slaby
Journal:  J Transl Med       Date:  2012-05-21       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.